Skip to content

Palmoplantar Pustulosis and Generalized Pustular Psoriasis: A National Population-based Analysis of Prevalence

Palmoplantar Pustulosis and Generalized Pustular Psoriasis: A National Population-based Analysis of Prevalence

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04566471
Enrollment
200
Registered
2020-09-28
Start date
2012-01-01
Completion date
2021-12-31
Last updated
2020-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Generalized Pustular Psoriasis, Palmoplantar Pustulosis

Keywords

Generalized pustular psoriasis, Palmoplantar pustulosis, Urban Employee Basic Medical Insurance (UEBMI) data, prevalence, incidence

Brief summary

This study plans to calculate the prevalence and incidence of palmoplantar pustulosis and generalized pustular psoriasis based on the national medical insurance data and analyze the composition characteristics and some clinical features of patients, through taking into account of the research status of palmoplantar pustulosis and generalized pustular psoriasis and the characteristics of medical insurance data.

Interventions

OTHERprevalence/incidence

It is an observational study for prevalence/incidence, no intervention provided.

Sponsors

Peking University Third Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* The insured population of the national urban employee basic medical insurance and the urban resident basic medical insurance from January 1, 2012, to December 31, 2016 (60 months) (the denominator) * The patients have been diagnosed with palmoplantar pustulosis or generalized pustular psoriasis (including disease name, English abbreviation and ICD code) * Both outpatient and inpatient patients are included

Exclusion criteria

* The individuals whose information is only contained in the reimbursement settlement database but not in the insurance coverage database will be considered as invalid reimbursement individuals and be excluded from the study (the denominator) * The patients have been diagnosed with non-PPP and -GPP diseases, such as pustular psoriasis in palm and toe, pustular arthritis osteitis and SAPHO syndrome

Design outcomes

Primary

MeasureTime frameDescription
prevalence of Palmoplantar pustulosisFrom 2012 to 2016 in the Urban Employee Basic Medical Insurance (UEBMI) data of ChinaEpidemiological characteristics of diseases: Mainly referring to indicators that could reflect the frequency related to the disease
prevalence of Generalized pustular psoriasisFrom 2012 to 2016 in the Urban Employee Basic Medical Insurance (UEBMI) data of ChinaEpidemiological characteristics of diseases: Mainly referring to indicators that could reflect the frequency related to the disease

Secondary

MeasureTime frameDescription
incidence of Palmoplantar pustulosisFrom 2012 to 2016 in the Urban Employee Basic Medical Insurance (UEBMI) data of ChinaEpidemiological characteristics of diseases: Mainly referring to indicators that could reflect the frequency related to the disease
incidence of Generalized pustular psoriasisFrom 2012 to 2016 in the Urban Employee Basic Medical Insurance (UEBMI) data of ChinaEpidemiological characteristics of diseases: Mainly referring to indicators that could reflect the frequency related to the disease
Economic burden of Palmoplantar pustulosisFrom 2012 to 2016 in the Urban Employee Basic Medical Insurance (UEBMI) data of ChinaMainly referring to the consumption of medical resources, including medical expenses of patients.
Economic burden of Generalized pustular psoriasisFrom 2012 to 2016 in the Urban Employee Basic Medical Insurance (UEBMI) data of ChinaMainly referring to the consumption of medical resources, including medical expenses of patients.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026